An updated model of a cycle-tracking bracelet offers users new and customizable features.
There has been a lot of buzz about Apple's foray into healthcare and reports of the company hiring "dozens" of medical doctors, but what does that actually mean for medtech?
Propeller Health, the University of Wisconsin-Madison, and the University of California, Berkeley, used digital medicine data obtained from a five-year study to find out how air pollution impacts the day-to-day lives of asthma sufferers.
Biomedical engineers at Georgia Tech have developed a smartphone app that uses photos of a patient's fingernails to determine whether the level of hemoglobin in their blood seems low.
Pear Therapeutics has received a nod from FDA to market reSET-O, an app used to help those with opioid use disorder stay in recovery programs.
The Dublin-based company will pick up Nutrino, a frequent collaborator and a company that uses artificial intelligence for nutrition-related services.
Right now we’re in the middle of the Artificial Intelligence Renaissance for medtech. But what does this mean for companies? Is this a fad or is AI here to stay in medtech. MD+DI Managing Editor Omar Ford gives his thoughts on this emerging trend.
The Mountain View, CA-based company isn’t out of diabetes completely, as it still has partnerships in the space with DexCom, Sensile, and Sanofi.
Artificial intelligence–powered software prioritizes the assessment of computed tomography cases that may have indications of brain bleed.
The spotlight will be on digital health products at the upcoming BIOMEDevice San Jose show. Hear now from one company making an impact.
Sweetch is using artificial intelligence to help change people’s lifestyles who are at risk for diabetes, which is a slightly different method for tackling the disease.
A presentation at the upcoming BIOMEDevice San Jose show will cover issues in connectivity for this growing segment of the medical device industry.
The Redwood City, CA-based company spent about $3.5 million in its patent dispute with Boston Scientific during 3Q18.